Bausch Lomb Financials

BLCO Stock  USD 15.56  0.19  1.21%   
Based on the measurements of operating efficiency obtained from Bausch Lomb's historical financial statements, Bausch Lomb Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Bausch Lomb's Other Stockholder Equity is very stable compared to the past year. Key indicators impacting Bausch Lomb's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.780.7391
Notably Up
Slightly volatile
Operating Income232.7 M162 M
Way Up
Slightly volatile
Current Ratio1.831.6041
Fairly Up
Slightly volatile
Investors should never underestimate Bausch Lomb's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Bausch Lomb's cash flow, debt, and profitability to make informed and accurate decisions about investing in Bausch Lomb Corp.

Net Income

(301.15 Million)

  
Understanding current and past Bausch Lomb Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bausch Lomb's financial statements are interrelated, with each one affecting the others. For example, an increase in Bausch Lomb's assets may result in an increase in income on the income statement.

Bausch Lomb Corp Earnings Geography

Bausch Lomb Stock Summary

Bausch Lomb competes with Cooper Companies,, ICU Medical, Hologic, Becton Dickinson, and Teleflex Incorporated. Bausch Lomb Corporation operates as an eye health company worldwide. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch Lomb operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 12500 people.
Foreign Associate
  Canada
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINCA0717051076
CUSIP071705107
LocationBritish Columbia; Canada
Business Address520 Applewood Crescent,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.bausch.com
Phone905 695 7700
CurrencyUSD - US Dollar

Bausch Lomb Key Financial Ratios

Bausch Lomb Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets11.3B10.8B11.1B13.4B13.5B13.1B
Other Current Liab730M832M901M1.0B1.3B1.0B
Net Debt(137M)(62M)2.1B4.2B4.5B4.7B
Accounts Payable178M239M370M522M389M359.3M
Cash238M174M354M331M305M292.2M
Net Receivables645M721M724M839M1.0B855.8M
Good Will4.7B4.6B4.5B4.6B4.5B3.7B
Inventory616M572M628M1.0B1.0B819.9M
Other Current Assets155M168M431M544M421M351.5M
Total Liab1.3B1.4B4.0B6.5B6.9B4.0B
Net Invested Capital9.9B9.3B9.5B11.4B11.3B11.2B
Total Current Assets1.7B1.6B2.1B2.7B2.8B2.3B
Net Working Capital745M536M841M1.2B1.1B915.8M
Short Term Debt18M28M25M30M40M28.8M
Intangible Assets2.6B2.3B2.1B3.6B3.5B3.1B

Bausch Lomb Key Income Statement Accounts

202020212022202320242025 (projected)
Tax Provision307M125M58M82M71M68.7M
Interest Expense19M63M146M283M399M419.0M
Total Revenue3.4B3.8B3.8B4.1B4.8B4.3B
Gross Profit2.1B2.3B2.2B2.5B2.9B2.7B
Operating Income260M329M207M130M162M232.7M
Ebit297M347M220M130M117M111.2M
Research Development253M271M307M324M361M313.5M
Ebitda739M762M599M512M162M153.9M
Cost Of Revenue1.3B1.5B1.5B1.6B1.9B1.6B
Income Before Tax290M318M73M(166M)(234M)(222.3M)
Net Income(17M)182M15M(260M)(317M)(301.2M)
Income Tax Expense307M125M58M82M71M68.7M
Minority Interest(1M)(11M)9M(12M)(10.8M)(10.3M)

Bausch Lomb Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(32M)(15M)(106M)(264M)(147M)(154.4M)
Investments3M(5M)(40M)(2.1B)(412M)(432.6M)
Change In Cash46M(61M)203M(46M)(18M)(17.1M)
Free Cash Flow263M664M170M(198M)(59M)(56.1M)
Depreciation442M415M379M382M436M344.9M
Other Non Cash Items9M59M(2M)72M19M27.5M
Capital Expenditures259M209M175M181M291M219.4M
Net Income(17M)193M15M(248M)(305M)(289.8M)
End Period Cash Flow238M177M380M334M316M286.8M
Change To Netincome72M157M248M(57M)(65.6M)(62.3M)

Bausch Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bausch Lomb's current stock value. Our valuation model uses many indicators to compare Bausch Lomb value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bausch Lomb competition to find correlations between indicators driving Bausch Lomb's intrinsic value. More Info.
Bausch Lomb Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Bausch Lomb's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bausch Lomb's earnings, one of the primary drivers of an investment's value.

Bausch Lomb's Earnings Breakdown by Geography

Bausch Lomb Corp Systematic Risk

Bausch Lomb's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bausch Lomb volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Bausch Lomb Corp correlated with the market. If Beta is less than 0 Bausch Lomb generally moves in the opposite direction as compared to the market. If Bausch Lomb Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bausch Lomb Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bausch Lomb is generally in the same direction as the market. If Beta > 1 Bausch Lomb moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Bausch Lomb Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bausch Lomb's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Bausch Lomb growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.88)

At this time, Bausch Lomb's Price Earnings To Growth Ratio is very stable compared to the past year.

Bausch Lomb March 21, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Bausch Lomb help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bausch Lomb Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bausch Lomb Corp based on widely used predictive technical indicators. In general, we focus on analyzing Bausch Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bausch Lomb's daily price indicators and compare them against related drivers.
When determining whether Bausch Lomb Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Lomb's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Lomb Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Lomb Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Lomb Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Earnings Share
(0.90)
Revenue Per Share
13.619
Quarterly Revenue Growth
0.091
Return On Assets
0.0096
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.